[Hypoplastic left heart syndrome]

Ko Yoshizumi1, Shunji Sano

  • 1Department of Cardiovascular Surgery, Okayama University Medical School, Okayama, Japan.

Insights

Prenatal diagnosis of hypoplastic left heart syndrome (HLHS) improves outcomes. A modified Norwood procedure using a right ventricular-pulmonary artery shunt offers a more stable surgical option for HLHS patients.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Defects
  • Neonatal Cardiology

Background:

  • Hypoplastic left heart syndrome (HLHS) remains a significant challenge in pediatric cardiac surgery.
  • Prenatal diagnosis of HLHS is crucial for effective preoperative management.
  • Outcomes for the Norwood procedure have improved due to surgical and perioperative advancements.

Purpose of the Study:

  • To evaluate the impact of prenatal diagnosis on HLHS patient outcomes.
  • To assess the efficacy of a modified Norwood procedure utilizing a right ventricular-pulmonary artery (RV-PA) shunt for HLHS palliation.

Main Methods:

  • Comparison of operative mortality between prenatally and postnatally diagnosed HLHS infants undergoing the Norwood operation.
  • Implementation of a modified Norwood procedure using a non-valved polytetrafluoroethylene (PTFE) graft for an RV-PA shunt.
  • Analysis of hemodynamic parameters, including diastolic blood pressure and Qp/Qs ratios, in patients receiving the RV-PA shunt.

Main Results:

  • Infants with prenatal HLHS diagnosis demonstrated improved operative mortality compared to those diagnosed postnatally.
  • The modified Norwood procedure with an RV-PA shunt led to higher diastolic blood pressures and lower Qp/Qs ratios.
  • Patients undergoing the RV-PA shunt palliation experienced more stable systemic circulation and required fewer ventilatory interventions.

Conclusions:

  • Prenatal diagnosis significantly enhances survival rates for HLHS patients.
  • The modified Norwood procedure with an RV-PA shunt provides a more stable and efficient palliative strategy for HLHS.
  • This surgical modification reduces hemodynamic instability and improves perioperative management in HLHS.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...